Gland Pharma Limited
ListedSMEHealthcare / Pharmaceuticals & Biotechnology · NSE / BSE
Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.
Price Band
₹1490 – ₹1500
Issue Size
₹6480 Cr
Lot Size
10 shares
GMP
₹118
+7.9%
Est. Listing
₹1618
at current GMP
Subscribed
—
Open
9 Nov 2020
Close
11 Nov 2020
Allotment
18 Nov 2020
Refund
19 Nov 2020
Demat Credit
20 Nov 2020
Listing
20 Nov 2020
Last updated 10 months ago
Overall Subscription
0.00x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 21,598,500 | — | 0.00x |
| Non-Institutional (NII / HNI) | 6,479,550 | — | 0.00x |
| Retail Individual (RII) | 15,118,950 | — | 0.00x |
| Total | 43,197,000 | 0 | 0.00x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 1,511,895 | 1,511,895 | 1.00x |
| HNIs (10L +) | 9,671 | 9,671 | 1.00x |
| HNIs (2-10L) | 46,283 | 46,283 | 1.00x |
| Total Applications | 1,567,849 | 1,567,849 | 1.00x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.